Hosted by the European Association for Cancer Research

Our increased understanding of the complexity of cancer has revealed a wide number of therapeutic targets, against which a diverse range of therapeutic strategies are required. Consequently, the repertoire of cancer drug discovery approaches has expanded significantly beyond the identification of traditional small molecule catalytic inhibitors or functional blocking antibodies. 

This conference will explore a breadth of new technical approaches to the identification and development of novel cancer therapeutics, including agents in early clinical development. The aim is to provide an accessible insight into recent developments in this rapidly evolving field, that aims to harness our insights from cancer research for the benefit of patients.

Abstract submission deadline: 29 July 2024

More information and to register